Back to Blog

Membranous Glomerulopathy Subtyping

Michael Kuperman, MD renal pathologist at arkana laboratories
By Michael Kuperman, MD

Nov 06, 2019

Membranous Glomerulopathy Subtyping, Arkana Laboratories, Renal Pathology Teaching Points

The diagnosis of membranous glomerulopathy has evolved rapidly in the past 10 years since the identification of PLA2R as the major target antigen in primary membranous glomerulopathy. Today, rather than subtyping into vague categories such as ‘primary’ and ‘secondary’, we have tools available to name the specific type of disease present in most cases. Arkana Laboratories offers diagnostic testing for membranous glomerulopathy including immunohistochemical stains for tissue typing of PLA2R, THSD7A, EXT1/2, and NELL1 membranous and serum testing to monitor disease in patients with PLA2R and THSD7A-associated membranous glomerulopathy.

 

Tags:

Quick note: This post is to be used for informational purposes only and does not constitute medical or health advice. Each person should consult their own doctor with respect to matters referenced. Arkana Laboratories assumes no liability for actions taken in reliance upon the information contained herein.